Cargando…
Sequential Profiling of Anti-SARS CoV-2 IgG Antibody in Post COVID-19 Patients
Upon SARS CoV-2 infection, humoral immune system triggers production of anti-SARS CoV-2 IgM and IgG antibodies. Currently, antibodies against SARS CoV-2 spike protein receptor binding domain play a central role in disease protection, making them potential target for in vitro diagnostics applications...
Autores principales: | Sukumaran, Ajaikumar, Thomas, Rhema Elizabeth, Krishnan, R. Arun, Thomas, Thushara, Thomas, Riji, Vijayan, Deepa K., Paul, Jofy. K., Vasudevan, D. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371431/ https://www.ncbi.nlm.nih.gov/pubmed/34421232 http://dx.doi.org/10.1007/s12291-021-00998-7 |
Ejemplares similares
-
COVID-19: Current Trends in Invitro Diagnostics
por: Arun Krishnan, R., et al.
Publicado: (2020) -
Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression
por: Thomas, Rhema Elizabeth, et al.
Publicado: (2022) -
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022) -
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020) -
Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2020)